{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-014473","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2025-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.901256+00:00","generated_at":"2026-05-27T08:18:26.719202+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeuroPace issues 2025 revenue guidance $92M-$96M; 3-year CAGR target 20%+","bullets":["2025 revenue guidance $92M-$96M (15.5%-20.5% YoY growth); gross margin 73%-75%; total OpEx $92M-$95M.","Three-year targets: 20%+ revenue CAGR, indication expansion to IGE/pediatric, AI tools, and cash flow breakeven.","Post-approval trial: 82% median seizure reduction at 36 months (n=255); 42.5% seizure-free ≥6 months; 22% ≥1 year.","NAUTILUS trial (IGE): 87 patients implanted; 1-yr follow-up due by March 2025; data lock Q2 2025; FDA submission H2 2025.","Plans to release first AI-powered electrographic seizure classifier tool within RNS System PDMS in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-014473","json":"https://secwatch.observer/filing/0001193125-25-014473.json","markdown":"https://secwatch.observer/filing/0001193125-25-014473.md","text":"https://secwatch.observer/filing/0001193125-25-014473.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000119312525014473/0001193125-25-014473-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000119312525014473/d877194d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T08:18:26.719202+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}